Prostate Health Index (phi) [Test in Focus] - Insights

Useful For Assessing the patient’s probability of having detectable prostate cancer when totalprostate specific antigen (PSA) concentrations are between

Mayo Clinic Laboratory and pathology research roundup: August 1 - Insights

This week's research roundup feature: A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.

Mayo Clinic Laboratory and pathology research roundup: June 27 - Insights

This week's research roundup feature: SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.

Mayo Clinic Laboratory and pathology research roundup: August 8 - Insights

This week's research roundup feature: Age-based versus young-adult thresholds for nephrosclerosis on kidney biopsy and prognostic implications for CKD.

Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights

This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.

4 statistics that showcase the broad impact of laboratory medicine - Insights

Medical Laboratory Professionals Week is a time to appreciate the profound impact of laboratory medicine on healthcare and innovation.

Gastrointestinal Pathogen Panel, PCR, Feces [Test in Focus] - Insights

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

New Test Options for NTRK Gene Fusions - Insights

The presence NTRK gene fusions is one of the eligibility requirements for the recently FDA-approved therapy Vitrakvi (larotrectinib), a therapy indicated in adult and pediatric patients with solid tumors regardless of the type of tumor....

Neuroimmunology: Updates and antibody test utilization - Insights

In this month’s “Hot Topic,” Andrew McKeon, M.B., B.Ch., M.D., reviews the use of neurological phenotype-based evaluations, the move away from the paraneoplastic evaluation, and upcoming changes to test profiles.

Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 17 - Insights

This week’s Research Roundup highlights the risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.